🔵 [PAS 2026] - Is Procalcitonin Plus CRP the Better Sepsis Screen for Febrile Infants?
The Incubator Channel · 26 Apr 2026 · 8 min
Summary
A Yale hospitalist presents a 106-site retrospective study at PAS 2026 comparing procalcitonin plus CRP against the 2021 AAP guideline marker combinations for risk-stratifying febrile infants aged 8-60 days. She discusses its similar sensitivity but higher specificity for invasive bacterial infection, the study's limitations, why preterm infants were excluded, and what guideline adoption would require.
Third-party teaching is shown for education. Check it against your unit's guidance.